OLGA and OLGIM staging systems on the risk assessment of gastric cancer: a systematic review and meta‑analysis of prospective cohorts
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Higher stages of Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) significantly increase gastric cancer (GC) risk. These validated systems aid GC risk assessment and surveillance program design.
Area Of Science
- Gastroenterology
- Oncology
- Epidemiology
Background
- The Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) are established classification systems.
- These systems are crucial for evaluating atrophic gastritis and intestinal metaplasia, respectively.
Purpose Of The Study
- To evaluate the association between OLGA and OLGIM scores and the risk of gastric cancer (GC).
- This evaluation was conducted using data exclusively from prospective cohort studies.
Main Methods
- A systematic review and meta-analysis of prospective cohort studies was performed.
- Studies were identified through systematic searches of four databases, focusing on OLGA/OLGIM staging systems and GC prediction.
- Pooled risk ratios (RR) and absolute risk differences were calculated, comparing higher stages (III-IV) with lower stages (0-II).
Main Results
- Eight studies comprising 12,526 patients were included.
- Higher OLGA (III-IV) and OLGIM (III-IV) stages were significantly associated with increased GC risk (RR 32.31 and 12.38, respectively).
- These stages correlated with a 4-5% absolute increase in GC risk, with findings consistent across high-incidence regions and excluding autoimmune gastritis cohorts.
Conclusions
- Advanced stages in both OLGA and OLGIM systems are linked to a substantially elevated risk of high-grade dysplasia (HGD) and GC.
- These findings validate the utility of OLGA and OLGIM scoring systems.
- The systems are valuable tools for assessing GC risk and informing the design of endoscopic surveillance strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Location of Pain:...